Quest PharmaTech Inc. announced the appointment of Mr. Mark Lievonen, to the Company's Board of Directors. Mr. Lievonen has over 30 years' experience in the pharmaceutical industry, more recently as the President of Sanofi Pasteur Limited, the Canadian vaccine division of Sanofi. The company also announced the resignation of Mr. Ian McConnan, FCA, from the company's Board of Directors. Mr. McConnan has been a company Board of Director for the past 14 years and served as Audit Committee Chair.